Fingerprint
Dive into the research topics of 'Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents
Lucas Moreno, Steven G. Dubois, Julia Glade Bender, Audrey Mauguen, Nick Bird, Vickie Buenger, Michela Casanova, François Doz, Elizabeth Fox, Lia Gore, Douglas S. Hawkins, Shai Izraeli, David T.W. Jones, Pamela R. Kearns, Jan J. Molenaar, Karsten Nysom, Stefan Pfister, Gregory Reaman, Malcolm Smith, Brenda Weigel
*Corresponding author for this work
- University of Barcelona
- Dana-Farber Cancer Institute
- Memorial Sloan-Kettering Cancer Center
- Solving Kids' Cancer UK
- Coalition Against Childhood Cancer (CAC2) Ethics Think Tank
- IRCCS Fondazione Istituto Nazionale per lo studio e la cura dei tumori - Milano
- Université de Paris
- Institut Curie
- St Jude Childrena's Research Hospital
- The Children's Hospital, Aurora
- University of Colorado Anschutz Medical Campus
- Seattle Childrena's Hospital
- Childrena's Oncology Group
- Schneider Childrens Medical Center Israel
- Tel Aviv University
- Hopp Childrena's Cancer Center Heidelberg (KiTZ)
- German Cancer Research Center
- University of Birmingham
- NIHR Birmingham Biomedical Research Centre
- University of Copenhagen
- KITZ
- Heidelberg University
- United States Food and Drug Administration
- National Institutes of Health
- University of Minnesota Twin Cities
- Innovative Therapies for Children with Cancer Consortium
- ACCELERATE
- Institut Gustave Roussy
- Princess Máxima Center for Paediatric Oncology
- Erasmus University Rotterdam
Research output: Contribution to journal › Article › Academic › peer-review